Welcome to our dedicated page for MSP Recovery news (Ticker: MSPR), a resource for investors and traders seeking the latest updates and insights on MSP Recovery stock.
MSP Recovery, Inc. (MSPR) generates news that spans healthcare reimbursement recoveries, technology initiatives, litigation developments, capital structure changes, and listing‑status updates. The company describes itself as a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, and its announcements often highlight how legal strategy and data analytics intersect in its business.
Readers following MSPR news can expect detailed updates on reimbursement recovery activities, including settlements with property and casualty insurers, pharmaceutical defendants, and group health plans. The company frequently reports on class actions and other litigation related to the Medicare Secondary Payer Act, as well as court decisions that affect the enforceability of its claim assignments. For example, MSP Recovery has publicized a ruling by the Supreme Court of Maryland upholding its assignment model, and it has described ongoing class action proceedings against a major auto insurer.
MSP Recovery’s news flow also covers technology and platform developments. The company issues updates on its LifeWallet ecosystem, which it says connects patients, providers, and payers, and on LifeChain, its blockchain‑based tokenization platform for medical claims developed with Tokenology Labs. Announcements describe the use of AI, natural language processing, and machine learning, as well as partnerships with technology firms such as Palantir Technologies, Inc.
Investors and observers will also find regular disclosures on capital and restructuring initiatives, including term sheets for new secured term loan facilities, bridge funding arrangements, debt‑to‑equity conversions, and modifications to equity purchase agreements. The company has reported reverse stock splits aimed at addressing Nasdaq bid‑price requirements, notices of non‑compliance with Nasdaq listing standards, and the subsequent decision to delist its common stock from Nasdaq with an expectation of trading on the OTCQB market.
Regulatory and governance topics appear in MSPR’s news as well, such as the conclusion of an SEC investigation without a recommendation of enforcement action, auditor transitions affecting filing timelines, and settlements that resolve previously disclosed litigation risks. For a consolidated view of these developments, the MSPR news page provides a chronological archive of company‑issued updates and related regulatory disclosures.
MSP Recovery (MSPR) has initiated claims exceeding $5.6 billion for payments due from major pharmaceutical companies. This follows an earlier announcement of $368 billion in owned claims. The company targets various recoveries, including product liability and antitrust claims, particularly against notable firms like AstraZeneca and Merck. MSPR is implementing strategies to enhance claims recovery, expecting continued growth in recovery volumes, with a total of $7.1 billion in billed amounts now being pursued.
MSP Recovery, Inc. (MSPR) announced significant updates on June 13, 2022. The company reported that the value of owned claims has surged to $368 billion. Additionally, MSPR is pursuing over $1.5 billion in claim demands from insurers. The company aims to utilize its Health Safety Technology, including biometric checks, to enhance healthcare accuracy and prevent fraud. MSPR also plans to implement this technology in Florida schools to improve safety and access to student health records. The firm highlights its rapid growth and unique expertise in healthcare data and recovery.
MSP Recovery, LLC (NASDAQ: MSPR) announced that its Founder and CEO, John H. Ruiz, purchased shares and warrants of the company. This transaction signifies Ruiz's confidence in MSP Recovery's prospects. Specific details of the purchase will be disclosed in a Form 4 filing by June 2, 2022. Since its establishment in 2014, MSP Recovery has positioned itself as a leader in Medicare, Medicaid, and secondary payer reimbursement recovery by leveraging technology to address inefficiencies in the healthcare reimbursement system. For more details, visit msprecovery.com.
MSP Recovery, LLC (MSPR) began trading on Nasdaq on May 24, 2022, after its merger with Lionheart Acquisition Corporation II (LCAP). MSPR is expanding through new revenue streams and aims to match or exceed its revenue guidance of $992 million for 2022. The company has solidified its business model through extensive due diligence, backed by over 150 entities. MSPR boasts a substantial claims portfolio of $1.5 trillion billed and $364.4 billion paid by 2021, with innovative software and litigation success in healthcare claims recovery.
MSP Recovery, Inc. (MSPR) announced that trading of its Class A Common Stock and warrants will commence on May 24, 2022 on Nasdaq following its business combination with Lionheart Acquisition Corporation II. This merger has an enterprise value of approximately $32.6 billion. MSPR has significantly increased its portfolio, reporting over $1.5 trillion in billed amounts as of December 31, 2021, reflecting a growth of over 530% since 2020. The company has also launched LifeWallet to enhance healthcare data access, aiming to improve patient outcomes.